Oncology & Cancer

Big data powers design of 'smart' cell therapies for cancer

Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research. In two new papers, scientists at UC San Francisco and Princeton University present complementary strategies ...

Oncology & Cancer

New prognostic markers for colon cancer identified

Gut-associated lymphoid tissue represents an integral part of the immune system. Among the powerful players of the mucosa-associated lymphoid tissue are isolated lymphoid structures (ILSs). Additionally, researchers have ...

Oncology & Cancer

A better test for the tumor-targeting of CAR-T therapies

Ludwig Cancer Research scientists have developed a method to significantly improve the preclinical evaluation of chimeric antigen-receptor (CAR) T cell therapies, in which the immune system's T cells are extracted from a ...

Oncology & Cancer

Scientists use two powerful immunotherapies to eradicate solid tumors

City of Hope scientists have combined two potent immunotherapies—an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy—to target and eradicate solid tumors that are otherwise difficult to treat with CAR ...

page 1 from 16